You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Dose dependent pharmacokinetics of citalopram in humans
- In: SIG Bioavailability/Bioequivalence - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: BB-P-040
- By: EMAMI, Jaber (Isfahan University of Medical Sciences, Isfahan, Iran)
- Co-author(s): Ali-Mohammad, Sabzghabaee (Isfahan University of Medical Sciences, ISFAHAN, Iran)
Hasan, Soleimani (Isfahan University of Medical Sciences, ISFAHAN, Iran)
Ramezani, Razieh (Isfahan University of Medical Sciences, ISFAHAN, Iran) - Abstract:
Introduction: Pharmacokinetics of citalopram have been well described after single doses of up to 60 mg (1). Administration of doses greater than 60 mg for resistant patients is routine (2). The objective of present study was, therefore, to investigate the pharmacokinetic behavior of citalopram after oral administration of single doses of 40 and..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026